文献速递糖尿病

美国医学研究所体重增长目标是否适用于妊娠期糖尿病女性?

Are the Institute of Medicine weight gain targets applicable in women with gestational diabetes mellitus?
PubMed 文献 · Diabetologia · 2016-12-09

该回顾性队列研究纳入1992至2013年3095例妊娠期糖尿病妊娠,按美国医学研究所(IOM)目标评估孕期体重增长过度与围产结局的关联。仅31.7%的孕期体重增长在IOM指南范围内;体重增长过度与剖宫产、大于胎龄儿及巨大儿风险升高相关,与小于胎龄儿风险降低相关。修改IOM标准(包括更严格的目标)未改善围产结局。

要点

  • 妊娠期糖尿病妊娠中仅31.7%的孕期体重增长符合IOM指南。
  • 体重增长过度与剖宫产、大于胎龄儿及巨大儿风险升高相关,与小于胎龄儿风险降低相关。
  • 修改IOM标准(包括更严格的目标)未改善围产结局。

核心结论

  • 按IOM目标定义的孕期体重增长过度与剖宫产、大于胎龄儿及巨大儿相关。
  • 修改IOM标准(包括更严格的目标)未改善围产结局。

研究设计与样本

  • 回顾性队列研究,纳入1992至2013年所有妊娠期糖尿病妊娠,共3095例。
  • 计算孕期体重增长过度(按IOM目标)与不良妊娠结局的OR,并校正母亲年龄、诊断时孕龄、孕前BMI、孕次、产次、族裔、产前空腹血糖、2小时血糖和HbA1c。
  • BMI分类:低体重(<18.5 kg/m2)、健康体重(18.5-24.9 kg/m2)、超重(25-29.9 kg/m2)、肥胖(≥30 kg/m2)。
  • 大于胎龄儿定义为出生体重高于第90百分位,小于胎龄儿定义为出生体重低于第10百分位,巨大儿定义为出生体重>4000 g,早产定义为37周前分娩。
  • 修改的孕期体重增长目标通过以下方式得出:(1)仅从IOM目标上限减去2 kg;(2)从上限和下限目标均减去2 kg;(3)按BMI分类使用适于胎龄儿女性的孕期体重增长四分位距;(4)BMI≥35 kg/m2的女性孕期体重增长限制在0-4 kg。

主要发现

  • 3095例妊娠期糖尿病妊娠中,仅31.7%的孕期体重增长在IOM指南范围内。
  • 孕期体重增长超过IOM目标的女性,剖宫产校正OR为1.5(95% CI 1.2, 1.9)。
  • 孕期体重增长超过IOM目标的女性,大于胎龄儿校正OR为1.8(95% CI 1.4, 2.4)。
  • 孕期体重增长超过IOM目标的女性,巨大儿校正OR为2.3(95% CI 1.6, 3.3)。
  • 孕期体重增长超过IOM目标的女性,小于胎龄儿风险较低,校正OR为0.5(95% CI 0.3, 0.7)。

关键数值与推荐

  • IOM孕期体重增长目标:仅31.7%的妊娠期糖尿病妊娠孕期体重增长在指南范围内。
  • 大于胎龄儿定义:出生体重高于第90百分位;小于胎龄儿定义:出生体重低于第10百分位;巨大儿定义:出生体重>4000 g;早产定义:37周前分娩。
  • BMI分类阈值:低体重<18.5 kg/m2,健康体重18.5-24.9 kg/m2,超重25-29.9 kg/m2,肥胖≥30 kg/m2。
  • 修改的孕期体重增长目标包括:从IOM上限减去2 kg、从上下限均减去2 kg、按BMI分类使用适于胎龄儿女性孕期体重增长的四分位距、BMI≥35 kg/m2者限制在0-4 kg。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Our aim was to study the relationship between excessive gestational weight gain (GWG) according to Institute of Medicine (IOM) targets and perinatal outcomes, and examine whether modifying targets may improve outcomes in women with gestational diabetes mellitus (GDM). METHODS: This was a retrospective cohort study of all GDM pregnancies from 1992 to 2013. ORs were calculated for associations between excessive GWG (EGWG) using IOM targets and adverse pregnancy outcomes. ORs were then adjusted for maternal age, gestational age at diagnosis, prepregnancy BMI, gravidity, parity, ethnicity, antenatal fasting blood glucose level (BGL), 2 h BGL and HbA1c. BMI was categorised into underweight (<18.5 kg/m2), healthy weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (≥30 kg/m2). Large for gestational age (LGA) was defined as birthweight above the 90th percentile, small for gestational age (SGA) was birthweight below the 10th percentile, macrosomia was birthweight >4000 g, and preterm delivery was delivery prior to 37 weeks' gestation. Modified GWG targets were derived by: (1) subtracting 2 kg from the upper IOM target only; (2) subtracting 2 kg from both upper and lower targets; (3) using the interquartile range of maternal GWG of women with infants who were appropriate for gestational age per BMI category; and (4) restricting GWG to 0-4 kg in women with BMI ≥35 kg/m2. RESULTS: Among 3095 GDM pregnancies, only 31.7% had GWG within IOM guidelines. Adjusted ORs for women who exceeded GWG were Caesarean section (1.5; 95% CI 1.2, 1.9), LGA (1.8; 95% CI 1.4, 2.4) and macrosomia (2.3; 95% CI 1.6, 3.3); there was a lower risk of SGA (adjusted OR 0.5; 95% CI 0.3, 0.7). CONCLUSIONS/INTERPRETATION: EGWG according to IOM targets was associated with Caesarean section, LGA and macrosomia. Modification of IOM criteria, including more restrictive targets, did not improve perinatal outcomes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Wong T, Barnes RA, Ross GP, et al. Are the Institute of Medicine weight gain targets applicable in women with gestational diabetes mellitus? Diabetologia. 2016. PMID: 27942798. doi:10.1007/s00125-016-4173-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。